News & Perspective

May 03, 2019

May 03, 2019

ASP Scan (Weekly) for May 03, 2019

Carbapenem reduction strategy
Quinolone ear drop risks
MDR Shigella in Vermont
US Candida auris uptick
Pause for antibiotic candidate
Fewer antibiotics for neonatal sepsis
Surgical prophylaxis risks
Rapid test for optimal antibiotics
CARB-X funding rounds
CRE infection outcomes
Reduced antibiotic for bacteriuria

Feb 09, 2015

Feb 09, 2015

Flu Scan for Feb 09, 2015

High-dose flu vaccine
H5N1 in British Columbia poultry
H5N1 cases in Egypt
H7N9 cases in China

Jan 29, 2015

Jan 29, 2015

News Scan for Jan 29, 2015

Flu vaccine in Canada
Egypt's H5N1 spike
H7N9 in China
Camera monitors in CDC labs

Jan 23, 2013

Jan 23, 2013

Research moratorium on modified H5N1 viruses ends

(CIDRAP News) – A year-long voluntary moratorium on research involving transmissible H5N1 avian flu viruses ended today with a letter from a group of scientists that supports resuming the work in countries that have addressed the biosafety issues involved.

Feb 17, 2011

Feb 17, 2011

WHO sticks with current strains for next flu vaccine

(CIDRAP News) – Signaling that the current flu strains are likely to persist over the next several months, the World Health Organization (WHO) today recommended sticking with the current trio of vaccine strains for the Northern Hemisphere's next influenza season.

The WHO's vaccine strain advisory committee met on Feb 15 and 16 and released its recommendation on the WHO's Web site. The group recommends the following for next season's vaccine:

Dec 23, 2010

Dec 23, 2010

US among countries reporting rise in flu activity

(CIDRAP News) – Influenza activity jumped in the United States last week along with other Northern Hemisphere locations, and an official from the World Health Organization (WHO) said it's not yet clear if this season will make its mark as a bad one.

Pages

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»